ENTEROL

Medicinal product

(Invented) name

ENTEROL

Active substance (s)

Liofilizuotos Saccharomyces boulardii CNCM I-745 ląstelės

Strength

250 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A07FA02, Saccharomyces boulardii

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2026-04-14

Date of renewal

Documents

3309_3310_ENTEROL_milt_ger_susp_kaps_PZ_2026-04-14.docx

3309_3310_ENTEROL_milt_ger_susp_kaps_PL_2026-04-14.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Kapsulėje yra	1 vnt.
Liofilizuotos Saccharomyces boulardii CNCM I-745 ląstelės	250 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
120501	106605	1106605	buteliukas	N10		Nereceptinis	LT/L/26/3310/001	Netiekiama	-	-	No	-	-	Download
120502	106606	1106606	buteliukas	N30 (3x10)		Nereceptinis	LT/L/26/3310/002	Netiekiama	-	-	No	-	-
120503	106607	1106607	buteliukas	N50 (5x10)		Nereceptinis	LT/L/26/3310/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-04-14	Registruotas